|
|
 |
POLYETHYLENE GLYCOL 600 Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
POLYETHYLENE GLYCOL 400 Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
POLYETHYLENE GLYCOL 1000 Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
OXLUMO Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|